生物材料用于向癌症中的内质网膜
Tripti Mishra1, Poulomi Sengupta2, Sudipta Basu1
1Department of Chemistry, Indian Institute of Technology Gandhinagar, Palaj, Gujarat, 382355, India.
Chemistry, an Asian journal
|April 11, 2024
概括
针对癌细胞中的内等质网膜 (ER) 提供了一种新的治疗策略. 生物材料正在开发中,以选择性地准ER,诱导压力,并帮助癌症治疗.
科学领域:
- 细胞生物学 细胞生物学
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 细胞内膜网膜 (ER) 对于蛋白质折叠,运输和平衡至关重要.
- 消化器功能障碍与疾病,特别是癌症有关.
- 在癌细胞中选择性ER向具有挑战性,因为缺乏特定的向部分.
研究的目的:
- 审查开发用于选择性ER向癌细胞的生物材料.
- 探索它们在诱导ER压力和用于癌症治疗的成像治疗方面的潜力.
- 讨论ER向癌症治疗的挑战和未来方向.
主要方法:
- 对用于ER向的各种生物材料的文献综述.
- 生物材料的分类包括碳/材料,脂质纳米粒子,超分子纳米结构,细胞膜涂层纳米粒子和金属纳米粒子.
- 分析它们损害和成像ER引发压力的机制.
主要成果:
- 许多生物材料已被研究用于癌症中ER向.
- 这些材料显示出选择性ER损伤和成像的潜力.
- 审查的生物材料旨在诱导ER压力作为一种抗癌战略.
结论:
- 生物材料在癌症治疗中为选择性内质网膜向提供了一个有希望的途径.
- 需要进一步的研究来克服挑战,并推进针对ER的癌症治疗.
- 下一代疗法可能会利用这些生物材料来改善癌症治疗结果.
更多相关视频
08:41Monitoring Endoplasmic Reticulum Calcium Homeostasis Using a Gaussia Luciferase SERCaMP
Published on: September 6, 2015
13.2K
07:54Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
8.2K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Endoplasmic Reticulum
94.9K
The Endoplasmic Reticulum (ER) in eukaryotic cells is a substantial network of interconnected membranes with diverse functions, from calcium storage to biomolecule synthesis. A primary component of the endomembrane system, the ER manufactures phospholipids critical for membrane function throughout the cell. Additionally, the two distinct regions of the ER specialize in the manufacture of specific lipids and proteins.
94.9K
Export of Misfolded Proteins out of the ER
3.6K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.6K
Smooth Endoplasmic Reticulum
5.7K
Smooth endoplasmic reticulum or smooth ER is a sub-organelle with specialized functions in animal cells and plant cells. It is often associated with the tubule morphology of the endoplasmic reticulum.
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
The ER provides optimal conditions for synthesizing steroid hormones and lipids, such as phospholipids and triglycerides. Traditionally, lipid metabolism was considered to be a smooth ER function. However, there is no direct evidence to prove that rough ER is completely excluded from lipid...
5.7K
ER Retrieval Pathway
3.8K
In the secretory pathway, vesicles transport proteins from one cellular compartment to another in forward transport to deliver the protein to its correct location. Occasionally, misfolded proteins and incorrect proteins escape their original compartments, and a retrieval pathway is used to return the escaped proteins to their original compartment.
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
The ER uses many checkpoints to prevent the entry of incorrectly folded or a resident protein as cargo onto a transport vesicle. These mechanisms...
3.8K
Tail-anchoring of Proteins in the ER Membrane
3.1K
Tail-anchored, or TA, proteins are estimated to make up to 3-5% of membrane proteins found in the eukaryotic cell. Such proteins have a single transmembrane domain located approximately 30 amino acid residues upstream from the C-terminal end. As a result, the signal recognition particle (SRP) cannot guide a TA protein to the ER membrane for cotranslational insertion. Hence, they are integrated into the ER membrane post-translationally using their C-terminal end as the anchor. TA proteins...
3.1K
